Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 25 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  2. US 8193194

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Jun 5, 2012 · Expires May 31, 2032

    granted
  3. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  4. US 8188071

    Amino substituted pyridines as potent kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  5. US 8187874

    Drug discovery method

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  6. US 8188283

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  7. US 8188095

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  8. US 8188134

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  9. US 8173635

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted
  10. US 8168798

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  11. US 8163720

    Pyrrolidinyl phenyl sulphonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  12. US 8163737

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  13. US 8163772

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  14. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  15. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  16. US 8158637

    Quinazolines useful as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  17. US 8153655

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  18. US 8153668

    Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  19. US 8153642

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  20. US 8143297

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  21. US 8129387

    Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  22. US 8129399

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  23. US 8129546

    Derivatives for modulation of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  24. US 8129381

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted